GlaxoSmithKline Signs Worldwide Acquisition for Toctino

Stiefel signs worldwide acquisition and license agreement for Toctino. Stiefel, a GlaxoSmithKline company, announced that it has entered into a worldwide agreement to acquire Toctino (alitretinoin) from Basilea Pharmaceutica.
Fox Business